Researchers discover drug that could combat brain cell death in those with Alzheimer’s disease.

Dr. Lin Jiang, Assistant Professor of Neurology at David Geffen School of Medicine at UCLA, was featured in an October 22 UCLA Newsroom article about him and his team members identified the plaque binding site of b-amyloid to its receptor by determining the three-dimensional structure. Knowledge of this interaction is a critical first step toward finding a drug to prevent the interaction between the toxic proteins and brain cells. Dr. Jiang and his team are using computer software to assist them in the drug selection process.